Document is current

Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

Crossref DOI link: https://doi.org/10.1136/jitc-2022-005414corr1

Published Online: 2023-01-12

Published Print: 2023-01

Update policy: https://doi.org/10.1136/crossmarkpolicy